Zydus Wellness is currently trading at Rs. 1283.00, up by 25.05 points or 1.99% from its previous closing of Rs. 1257.95 on the BSE.
The scrip opened at Rs. 1357.00 and has touched a high and low of Rs. 1357.00 and Rs. 1265.00 respectively. So far 2038 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1830.00 on 03-Sep-2018 and a 52 week low of Rs. 875.80 on 10-Nov-2017.
Last one week high and low of the scrip stood at Rs. 1,357.00 and Rs. 1237.55 respectively. The current market cap of the company is Rs. 4945.94 crore.
The promoters holding in the company stood at 72.54%, while Institutions and Non-Institutions held 13.64% and 13.82% respectively.
Zydus Wellness has signed definitive agreements to acquire the subsidiary of Kraft Heinz, Heinz India jointly with Cadila Healthcare. This will include the brands Complan, GluconD, Nycil and Sampriti Ghee, two large manufacturing facilities in Aligarh and Sitarganj and teams devoted to operations, research, sales, marketing and support. Heinz India also has a strong distribution network of over 800 distributors, more than 20,000 wholesalers covering 29 states.
The acquisition offers the right fit in terms of well entrenched brands in the fast growing categories of food, nutrition and skin care. The acquired brands have a strong market Presence and have a legacy of over 50 years.
Zydus Wellness is an integrated consumer company. The company is engaged in the development, production, marketing and distribution of health and wellness products.
